See the DrugPatentWatch profile for Klisyri
What is Klisyri in Australia?
Klisyri is the brand name used in Australia for tirbanibulin cream, a prescription medicine applied to the skin for treatment of actinic keratosis (also called solar keratosis), which is caused by long-term sun exposure.
What conditions does it treat?
In Australia, tirbanibulin cream (Klisyri) is used for actinic keratosis on the face or scalp (areas where actinic keratoses commonly occur).
How is Klisyri used?
Klisyri is a topical cream that patients apply to the affected skin area on a schedule provided by their prescriber (the regimen is typically short-course for actinic keratosis).
Is it prescription-only in Australia?
Yes. Klisyri is supplied as a prescription medicine in Australia.
What should patients expect (side effects)?
Topical tirbanibulin products commonly cause local skin reactions at the application site, such as redness, irritation/burning, and flaking or peeling. More severe reactions should be discussed with a clinician.
Are there related patents or substitutes?
If you are looking for patent/exclusivity details or comparable products, DrugPatentWatch.com tracks this kind of information; you can search there for tirbanibulin and brand names tied to the same active ingredient.
Source: DrugPatentWatch.com
What do you need from it—buying, dosing, or availability?
“Klisyri australia” can mean different things depending on what you’re trying to do. If you tell me which you want:
- how to get it (chemist availability / PBS listing if applicable),
- exact dosing instructions,
- where it’s indicated (face/scalp vs other areas),
- or cost/alternatives,
I can narrow the answer to that.